Apex Capital Management - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 204 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Apex Capital Management ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$12,591,000
-49.2%
235,567
+7.3%
0.28%
-50.0%
Q4 2015$24,796,000
+399.7%
219,488
+420.7%
0.55%
+394.6%
Q3 2015$4,962,00042,1510.11%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$120,640,00041.48%
Palo Alto Investors LP 2,187,242$247,093,00013.75%
VHCP Management, LLC 140,756$15,901,0009.61%
HWG Holdings LP 48,910$5,525,0005.62%
KINGDON CAPITAL MANAGEMENT, L.L.C. 906,287$102,383,0004.98%
Baker Brothers Advisors 4,198,520$474,307,0003.93%
Asymmetry Capital Management, L.P. 15,591$1,761,0002.66%
NEXT CENTURY GROWTH INVESTORS LLC 496,744$56,117,0002.42%
AlpInvest Partners B.V. 11,551$1,305,0002.17%
Atika Capital Management LLC 36,000$4,067,0002.09%
View complete list of ANACOR PHARMACEUTICALS INC shareholders